Who we are

Hej!
Welcome to PharmaLex Sweden

The Swedish team is comprised of dedicated professionals with backgrounds in the pharmaceutical industry, the pharmacy profession and academic research institutes. Our ambition is to produce creative, high-quality work meeting the highest standards of scientific rigor and real-world applicability.

 

  • According to therapeutic area, business potential, and company resources, we support our clients within health economics, reimbursement, real-world evidence, and market access strategy, as well as local PV/REG consultancy.

 

  • The team have in-depth knowledge of the Nordic market culture and authorities` expectations, while also providing the know-how to assist our Nordic clients in accessing mature international markets.

 

  • As part of the global PharmaLex group, PharmaLex Sweden is your local point of contact reaching the entire PharmaLex service portfolio, servicing more than 600 national and global companies

Local Contact

  • Åsa Pihlblad
    Country Manager - PharmaLex Sweden PharmaLex Sweden Medicinaregatan 8B
    Gothenburg
    SE-413 90
    Sweden    +46 31 724 22 01
Download Terms and Conditions
Explore PharmaLex Market Access offersEarly Phase Modeling InfographicVirtual GxP AuditsReal World Evidence Fact Flyer
Auditing-services

PharmaLex.perts to guide you for HTA advice that makes a difference

Since 2003, PharmaLex Sweden, formerly known as Nordic Health Economics, offers highly qualified health-economic services throughout the development process of pharmaceuticals and medical technology-products.

We start by offering strategic advice in the early stages of product development, on how product opportunities and challenges could be addressed to optimize the possibilities for inclusion into reimbursement schemes. We then follow this by developing the core material in preparation of reimbursement applications, and if applicable, also including collection of Real-World-Evidence to support the cost-effectiveness of the product. We have an unparalleled base of knowledge how to effectively develop the appropriate evidence according to legislation and policies of the boards in the respective countries, and how to communicate the results in a manner that clearly presents relevant information and the validity of the results.

Get in touch to see how we can be of service.

Related News

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • We needed a partner to help us obtain device approval. PharmaLex have not only helped us achieve this but are now providing on-going post-marketing surveillance support. We would highly recommend them to anyone who needs specialist expertise.

    Med Device company, US
    Senior Regulatory Affairs Director

  • In these unprecedented times, PharmaLex continues to support all clients by meeting virtually and providing experienced, remote-based consultants.

    PharmaLex Team Thomas
    Thomas Dobmeyer, CEO PharmaLex
    CEO PharmaLex

  • Thanks so much for your support over the past 30 days. Your commitment and timely communication have made working with you all a pleasant experience.

    US Biotech
    Senior QA Associate

  • They are available when we need to talk to them despite any time zone differentials

    Japan based medium sized company
    Manager